We are live on ! Find out more
DAM

DLD Asset Management Portfolio holdings

AUM $1.51B Turnover 51.11%
1-Year Est. Return 5.32%
This Fund
S&P 500
This Quarter Est. Return
+0.72%
1 Year Est. Return
+5.32%
3 Year Est. Return
+10.27%
5 Year Est. Return
+32.59%
10 Year Est. Return
–
AUM
$1.98B
AUM Growth
-$426M
Cap. Flow
-$1.24B
Cap. Flow %
-62.95%
Top 10 Hldgs %
72.69%
Holding
122
New
35
Increased
10
Reduced
14
Closed
43
Avg Time Held Equity + Options
0.3 years
Top 10 Avg Time Held Equity + Options
0.4 years
Top 20 Avg Time Held Equity + Options
0.3 years
Avg Time Held Equity only
0.3 years
Top 10 Avg Time Held Equity only
0.5 years
Top 20 Avg Time Held Equity only
0.3 years

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$22.6M
2
WCG
Wellcare Health Plans, Inc.
WCG
+$22.1M
3
VIAB
Viacom Inc. Class B
VIAB
+$7.2M
4
GWR
Genesee & Wyoming Inc.
GWR
+$6.88M
5
CBM
Cambrex Corporation
CBM
+$6.43M

Top Sells

Rank Stock Value
1
LLL
L3 Technologies, Inc.
LLL
+$55.4M
2
RHT
Red Hat Inc
RHT
+$45.1M
3
APC icon
Anadarko Petroleum
APC
+$39.2M
4
FDC
First Data Corporation
FDC
+$38.2M
5
STI icon
SunTrust Banks, Inc.
STI
+$28.6M

Sector Composition

Rank Sector Weight
1 Miscellaneous 86.66%
2 Healthcare 7.21%
3 Consumer Discretionary 1.63%
4 Industrials 1.46%
5 Communication Services 1.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$808B
$297M 15.02%
1,000,000
-800,000
-44% -$236M
2019 Q1
2 quarters
MDCO
2
PUT
DELISTED
Medicines Co
MDCO
$166M 8.39%
3,311,400
+393,600
+13% +$15.7M
2018 Q1
6 quarters
SPY icon
3
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$808B
$74.2M 3.75%
+250,000
New +$73.9M
2019 Q3
0 quarters
BIIB icon
4
CALL
Biogen
BIIB
$35.3B
$70.7M 3.58%
+303,400
New +$70.6M
2019 Q3
0 quarters
CELG
5
DELISTED
Celgene Corp
CELG
$44.7M 2.26%
450,000
-50,000
-10% -$4.75M
2019 Q1
2 quarters
AGN
6
DELISTED
Allergan plc
AGN
$35.3M 1.79%
210,000
+138,755
+195% +$22.6M
2019 Q2
1 quarter
WBC
7
DELISTED
WABCO HOLDINGS INC.
WBC
$28.6M 1.45%
213,625
+28,625
+15% +$3.81M
2019 Q1
2 quarters
WCG
8
DELISTED
Wellcare Health Plans, Inc.
WCG
$20.7M 1.05%
+80,000
New +$22.1M
2019 Q3
0 quarters
ADSW
9
DELISTED
Advanced Disposal Services Inc
ADSW
$16.8M 0.85%
515,453
+90,453
+21% +$2.93M
2019 Q2
1 quarter
ZAYO
10
DELISTED
Zayo Group Holdings, Inc.
ZAYO
$15.2M 0.77%
449,819
+40,000
+10% +$1.35M
2019 Q2
1 quarter
ONCE
11
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$13.8M 0.7%
142,500
-47,750
-25% -$4.78M
2019 Q1
2 quarters
ATEX icon
12
CALL
Anterix
ATEX
$1.6B
$12.1M 0.61%
+335,600
New +$14.1M
2019 Q3
0 quarters
ACAD icon
13
CALL
Acadia Pharmaceuticals
ACAD
$3.37B
$9.46M 0.48%
+263,000
New +$7.97M
2019 Q3
0 quarters
GWPH
14
PUT
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$7.82M 0.4%
+68,000
New +$10.3M
2019 Q3
0 quarters
EE icon
15
DELISTED
El Paso Electric Company
EE
$7.82M 0.4%
116,524
+46,524
+66% +$3.09M
2019 Q2
1 quarter
CBM
16
DELISTED
Cambrex Corporation
CBM
$7.14M 0.36%
+120,000
New +$6.43M
2019 Q3
0 quarters
GWR
17
DELISTED
Genesee & Wyoming Inc.
GWR
$6.91M 0.35%
+62,516
New +$6.88M
2019 Q3
0 quarters
TVTX icon
18
PUT
Travere Therapeutics
TVTX
$5.08B
$6.46M 0.33%
557,100
-286,100
-34% -$4.73M
2019 Q1
2 quarters
VIAB
19
DELISTED
Viacom Inc. Class B
VIAB
$6.2M 0.31%
+257,903
New +$7.2M
2019 Q3
0 quarters
CBLK
20
DELISTED
Carbon Black, Inc. Common Stock
CBLK
$5.98M 0.3%
+230,087
New +$5.08M
2019 Q3
0 quarters
GHDX
21
DELISTED
Genomic Health, Inc.
GHDX
$5.43M 0.27%
+80,000
New +$5.49M
2019 Q3
0 quarters
PACB icon
22
Pacific Biosciences
PACB
$594M
$5.16M 0.26%
1,000,000
-500,000
-33% -$2.8M
2018 Q4
3 quarters
MCRN
23
DELISTED
Milacron Holdings Corp.
MCRN
$5M 0.25%
+300,000
New +$4.83M
2019 Q3
0 quarters
PVTL
24
DELISTED
Pivotal Software, Inc.
PVTL
$4.48M 0.23%
+300,000
New +$3.67M
2019 Q3
0 quarters
GOSS icon
25
PUT
Gossamer Bio
GOSS
$53.9M
$4.34M 0.22%
+3,233
New +$5.14M
2019 Q3
0 quarters
1
2 3 4 5

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.51B AUM 33.02% 1-Year Est. Return
SC
Styrax Capital New York $1.52B AUM 57.44% 1-Year Est. Return
HCM
Hodges Capital Management Dallas, Texas $1.51B AUM 85.85% 1-Year Est. Return
NB
NBT Bank Norwich, New York $1.51B AUM 24.9% 1-Year Est. Return
WFA
Wellspring Financial Advisors Cleveland, Ohio $1.52B AUM 29.68% 1-Year Est. Return
RIM
Rush Island Management New York $1.51B AUM 8.12% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.52B AUM 3.09% 1-Year Est. Return

DLD Asset Management's Q3 2019 Portfolio in Review

As of Q3 2019, DLD Asset Management held 122 positions worth $1.98B, down 18% from $2.4B the previous quarter. Its ten largest holdings account for 73% of the portfolio.

DLD Asset Management withdrew a net $1.24B in Q3 2019, closing 43 positions and reducing 14 holdings. Its most notable exit was L3 Technologies, Inc., an estimated $55.4M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 87% of assets, up from 77% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, DLD Asset Management opened a new position in Wellcare Health Plans, Inc. worth $20.7M.

  • DLD Asset Management's largest Q3 2019 buy was Wellcare Health Plans, Inc.: 80,000 shares worth $20.7M.
  • DLD Asset Management added most to Allergan plc in Q3 2019, an estimated $22.6M increase.
  • DLD Asset Management's biggest Q3 2019 reduction was SunTrust Banks, Inc., cutting an estimated $28.6M.
  • DLD Asset Management fully exited L3 Technologies, Inc. in Q3 2019, selling an estimated $55.4M.
  • DLD Asset Management's ten largest holdings make up 73% of its $1.98B portfolio in Q3 2019.
  • DLD Asset Management opened 35 new positions and closed 43 in Q3 2019.
  • DLD Asset Management's portfolio value fell 18% quarter-over-quarter to $1.98B.

Based on DLD Asset Management's 13F filing for Q3 2019, filed 12 Nov 2019.